Condition: Monogenic Obesity · Sponsor: Prof. Dr. Martin Wabitsch
This observational study aims to assess the effect of once-weekly s.c. semaglutide 2.4 mg as an adjunct to a calorie-reduced diet and increased physical activity on weight loss, change in hunger, body composition, depression, and quality of life after 68 weeks of treatment in adolescents diagnosed with monogenic obesity in routine clinical care.
This description comes directly from the study's public registry record.
Martin Wabitsch, Prof. Dr. · +4973150057401 · martin.wabitsch@uniklinik-ulm.de
Stefanie Zorn, Dr. · +4973150057457 · stefanie.zorn@uniklinik-ulm.de
Always discuss trial participation with your own doctor first.
| Assistance Publique-Hôpitaux de Paris (AP-HP), Trousseau Hospital Paris, Pediatric Nutrition Department | Paris, France | Not Yet Recruiting |
| Institute for Experimental Pediatric Endocrinology, Charité Universitätsmedizin Berlin | Berlin, Germany | Not Yet Recruiting |
| University Hospital for Children and Adolescents, Center for Pediatric Research, Medical Faculty, University of Leipzig | Leipzig, Germany | Not Yet Recruiting |
| Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, Ulm University Medical Centre | Ulm, Germany | Recruiting |
| University Medical Center Rotterdam, Erasmus MC-Sophia Children's Hospital | Rotterdam, Netherlands | Not Yet Recruiting |
| Departments of Pediatrics & Pediatric Endocrinology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid | Madrid, Spain | Not Yet Recruiting |
| Wellcome-MRC Institute of Metabolic Science and NIHR Cambridge Biomedical Research Centre | Cambridge, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07302802